Immediate Impact
1 by Nobel laureates 53 standout
Citing Papers
MDM2 Inhibitors for Cancer Therapy: The Past, Present, and Future
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Lindi Chen being referenced
Preclinical evaluation of the first intravenous small molecule MDM2 antagonist alone and in combination with temozolomide in neuroblastoma
2018
Pre-clinical evaluation of the MDM2-p53 antagonist RG7388 alone and in combination with chemotherapy in neuroblastoma
2015
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lindi Chen | 205 | 132 | 133 | 203 | 8 | 331 | |
| Scarlett Czarnecki | 162 | 61 | 98 | 194 | 10 | 313 | |
| Anne-Catherine Jallas | 65 | 184 | 75 | 193 | 8 | 322 | |
| Federica Lorenzi | 44 | 185 | 104 | 223 | 8 | 361 | |
| Elizabeth R. Tucker | 124 | 65 | 68 | 160 | 11 | 263 | |
| Anna Kock | 97 | 85 | 98 | 109 | 11 | 304 | |
| Kateřina Čapková | 166 | 90 | 24 | 149 | 10 | 358 | |
| Peter Stroeken | 100 | 66 | 74 | 235 | 9 | 348 | |
| Fieke Lamers | 135 | 127 | 74 | 242 | 9 | 339 | |
| E Koeneke | 63 | 102 | 35 | 286 | 6 | 333 | |
| Franziska Trippel | 43 | 80 | 69 | 293 | 7 | 352 |
All Works
Login with ORCID to disown or claim papers
Loading papers...